Promising cream combo may stop skin cancer before it starts
NCT ID NCT04091022
First seen Jan 05, 2026 · Last updated May 13, 2026 · Updated 23 times
Summary
This study tested whether applying two FDA-approved creams (diclofenac and DFMO) to the skin could prevent new non-melanoma skin cancers in 64 people who had already been treated for skin cancer. Participants used the creams or a placebo for a period and were monitored for new skin growths. The goal was to see if the combination could reduce the number of new cancers compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MELANOMA SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Birmingham VA Medical Center
Birmingham, Alabama, 35233, United States
-
UAB Dermatology
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.